Author/Authors
Koçbıyık, Sibel Atatürk Eğitim ve Araştırma Hastanesi - Psikiyatri Kliniği, Turkey , Batmaz, Sedat Gaziosmanpaşa Üniversitesi - Tıp Fakültesi - Ruh Sağlığı ve Hastalıkları Anabilim Dalı, Turkey , Turhan, Levent Kartal Lütfi Kırdar Eğitim ve Araştırma Hastanesi - Psikiyatri Kliniği, Turkey , Yüncü, Özgür Ahmet Ankara Eğitim ve Araştırma Hastanesi - Psikiyatri Kliniği, Turkey , Çayköylü, Ali Yıldırım Beyazıt Üniversitesi - Tıp Fakültesi - Ruh Sağlığı ve Hastalıkları Anabilim Dalı, Turkey
Title Of Article
Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
شماره ركورد
24037
Abstract
Antidepressants, frequently prescribed in depression and anxiety disorders, are known to be risk factors for an increase in bleeding. Yet, unfavourable effects of selective serotonin reuptake inhibitör (SSRI) treatment on hemostasis have rarely been reported. The most frequently reported side effects of SSRIs on the hematologic system are prolonged bleeding time, impaired thrombocyte aggregation and activity. Here we present a case in whom ecchymotic lesions occurred with esscitalopram and fluoxetine and resolved with reboxetine.
From Page
90
NaturalLanguageKeyword
SSRI , ecchymotic lesion , bleeding
JournalTitle
Cukurova Medical Journal
To Page
93
JournalTitle
Cukurova Medical Journal
Link To Document